The Glaucoma Research Foundation (GRF) announced it has appointed Cynthia Steel, PhD, MBA, as Chief Scientific Officer (CSO).

PainReform announced it has acquired a majority equity interest in LayerBio, focusing on LayerBio's OcuRing-K technology, for ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Sandoz will oversee commercialization of the product across the European Union (excluding Germany), Switzerland, Norway, ...

The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...

The ADAPT study will evaluate the safety and effectiveness of the Calibreye surgical system in up to 70 patients with ...

This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

PA5108 is a rod-shaped, biodegradable microimplant designed to significantly reduce IOP in patients with primary open-angle ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

New research reveals that increased physical activity significantly slows visual field loss in glaucoma patients, ...